Sumitomo Pharma Shares Plunge Despite Parkinson's Treatment Greenlight

Shares of Japan's Sumitomo Pharma fell over 12% due to profit-taking, even after a specialist panel endorsed its iPS cell-based therapy for Parkinson's.

20 Feb, 02:26 — 20 Feb, 02:26

Post Share

Read at source (1 outlet)

cnbc3h ago

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment

Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.

Read full article →

PERSPECTA

Sumitomo Pharma Shares Plunge Despite Parkinson's Treatment Greenlight

Read at source (1 outlet)

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment

Related Stories

Egyptian Premier League 18th Matchday Fixtures and Results

United States beat Canada in overtime for women's ice hockey gold - Reuters

Johnson and McCollum power Hawks past the 76ers 117-117 as Atlanta snaps 3-game skid - AP News

The Overtime Hero Who Saved American Hockey - The Wall Street Journal